MedTrace Logo

Hyperbaric Oxygen Therapy After Stroke - PILOT

NCT04149379 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2020-04-27

No results posted yet for this study

Summary

The goal of this pilot study is to establish more information about hyperbaric oxygen therapy for this group of patients, and give us more information of how to initiate the best possible main study. Can we find any indications that support the use of this therapy for patients suffering from chronic disability after cerebral infarction? Can we improve physical and cognitive function.

Conditions

  • Cerebral Stroke

Interventions

DRUG

Hyperbaric oxygen

20 sessions of hyperbaric therapy in a pressure chamber at 2,4 absolute atmospheres, 90 minutes per day of breathing 100% medical oxygen through an own mask. Table 14/90.

Sponsors & Collaborators

  • Western Norway University of Applied Sciences

    collaborator OTHER

  • Helse-Bergen HF

    collaborator OTHER

  • Norwegian Underwater Intervention (NUI)

    lead INDUSTRY

Principal Investigators

  • Tobba T Südmann, PhD · Western Norway University of Applied Sciences

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-20
Primary Completion
2021-08-31
Completion
2021-12-20

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04149379 on ClinicalTrials.gov